Clinical Trial

Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke

Name: Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke — clinical trial record (NCT07163702)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: EXACT

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a Ⅱa clinical trial. The purpose of this study is to preliminarily explore the optimal dosage of Xinglou Chengqi Granules in the treatment of acute ischemic stroke and to evaluate the efficacy and safety of Xinglou Chengqi Granules for acute ischemic stroke.

Trial Details

NCT Number	NCT07163702
Lead Sponsor	Dongzhimen Hospital, Beijing
Conditions	Acute Ischemic Stroke
Enrollment	60 participants
Start Date	2025-10-01
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-09-09